Q/C TECHNOLOGIES, INC. (QCLS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch QCLS
See up to 3 months of QCLS. The 7-day demo opens the 1M and 3M ranges and puts QCLS on your watchlist.
Start 7-day demoLatest QCLS insider trades
About Q/C TECHNOLOGIES, INC. (QCLS)
The SEC lists Q/C TECHNOLOGIES, INC. under CIK 0001321834, in in vitro and in vivo diagnostic substances. We track it alongside the rest of the Health Care sector.
QCLS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 116,806 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
QCLS insider transactions (Form 4)
2621 Form 4 filings on record, the earliest from Oct 3, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Joshua Silverman - Officer | Grant or award | Common Stock | 16,806 | $0.00 footnote F1 | - | |
| Joshua Silverman - Officer | Grant or award | Employee Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| ||||||
| Chelsea Sierra Voss - Director | Open-market purchase | Common stock | 1,753 | $3.15 | $6K | |
| Stephen Friscia - Director | Grant or award | Employee Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Chelsea Sierra Voss - Director | Grant or award | Employee Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
 Billy Joe White - Director | Grant or award | Employee Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Mitchell Glass - Officer | Grant or award | Employee Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Joshua Silverman - Officer | Grant or award | Common stock | 162,162 | $0.00 footnote F1 | - | |
| Joshua Silverman - Officer | Grant or award | Employee Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| ||||||
| Bruce Bernstein - Director | Grant or award | Employee Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Chelsea Sierra Voss - Director | Grant or award | Common stock | 212,500 | $0.00 footnote F1 | - | |
| Chelsea Sierra Voss - Director | Grant or award | Common stock | 25,000 | $0.00 footnote F2 | - | |
| Chelsea Sierra Voss - Director | Grant or award | Employee Stock Option (Right to Buy) | 212,500 | $0.00 | - | |
| ||||||
| PharmaCyte Biotech, Inc. - 10% Owner | Open-market purchase | Series H Convertible Preferred Stock | 889,865 | - footnote F1 | - | |
| PharmaCyte Biotech, Inc. - 10% Owner | Open-market purchase | Warrants | 889,865 | - footnote F1 | - | |
| ||||||
| Mitchell Glass - Officer | Grant or award | Common stock | 11,420 | $0.00 footnote F1 | - | |
| ||||||
| Billy Joe White - Director | Grant or award | Common stock | 22,839 | $0.00 footnote F1 | - | |
| ||||||
| Joshua Silverman - Officer | Grant or award | Common stock | 91,356 | $0.00 footnote F1 | - | |
| ||||||
| Stephen Friscia - Director | Grant or award | Common stock | 22,839 | $0.00 footnote F1 | - | |
| ||||||
| Bruce Bernstein - Director | Grant or award | Common stock | 25,000 | $0.00 footnote F1 | - | |
| ||||||
 Gary M. Rauch | Grant or award | Common stock | 11,420 | $0.00 footnote F1 | - | |
| ||||||
| Billy Joe White - Director | Grant or award | Common stock | 2,161 | $0.00 footnote F1 | - | |
| ||||||
| Joshua Silverman - Officer | Grant or award | Common stock | 8,644 | $0.00 footnote F1 | - | |
| ||||||
| Gary M. Rauch | Grant or award | Common stock | 1,080 | $0.00 footnote F1 | - | |
| ||||||
| Mitchell Glass - Officer | Grant or award | Common stock | 1,080 | $0.00 footnote F1 | - | |
| ||||||
| Stephen Friscia - Director | Grant or award | Common stock | 2,161 | $0.00 footnote F1 | - | |
| ||||||
Item 1.01, 5.02, 7.01, 9.01
Item 1.02, 5.02, 9.01
Item 1.02, 8.01
Item 4.01, 9.01
QCLS insider trading FAQ
What is the latest insider trade for QCLS?
Q/C TECHNOLOGIES, INC. (QCLS) had 1 insider filing in the last 90 days, with the most recent on 2026-10-02. The full record for QCLS runs to 21 Form 4 filings, the earliest from 2025-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying QCLS stock?
No insider purchases of QCLS were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling QCLS stock?
No insider sales of QCLS were filed in the last 90 days.
Where can I see QCLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects QCLS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joshua Silverman view on EDGAR
- - Chelsea Sierra Voss view on EDGAR
- - Stephen Friscia view on EDGAR
- - Chelsea Sierra Voss view on EDGAR
- - Billy Joe White view on EDGAR
- - Mitchell Glass view on EDGAR
- - Joshua Silverman view on EDGAR
- - Bruce Bernstein view on EDGAR
- - Chelsea Sierra Voss view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where QCLS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow QCLS with a 7-day demo
- QCLS on your watchlist
- Every QCLS Form 4 filing on record
- Up to 3 months of QCLS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
